Frequent searches
Suggestions

Abstracts

GAMRIC welcomes the submission of abstracts to be considered for inclusion in the conference poster sessions as well as a small number being selected for short lightning talks within the main conference programme. Encore abstracts (abstracts previously shown at larger meetings) are also eligible for submission, especially if they include new data or explore new angles of research. 

Abstract submission

Regular and late-breaker abstract submissions are now closed. 

Information for poster presenters

Display boards are reserved for all posters that are accepted for GAMRIC. Posters should be mounted upon arrival and displayed for the entire duration of the conference. Presenters will receive an email with the exact date and time of their poster presentation(s). Presenters are strongly encouraged to actively participate in these sessions to network, personally share, and discuss their research with the community.

Posters should be size A0 portrait orientation. Please note that there will be no poster printing onsite.

Presenters may use the GAMRIC poster template

Poster sessions

Category 1: Early discovery and development
Category 2: Preclinical development
Category 3: Clinical development
Category 4: New antibacterial or antifungal classes
Category 5: Non-traditional approaches

Category 6: Stewardship, antimicrobial supply and access
Category 7: AMR diagnostics
Category 8: Preventatives / vaccines
Category 9: AMR epidemiology

Top rated abstracts

Presenter

Abstract title

Category

Poster session

Nina Perry

Investigating flap endonucleases as potential novel antimicrobial targets

1. Early discovery and development

Tuesday, 22 September

Prakash Jha

AI-driven discovery of dual-target inhibitors targeting metabolic vulnerabilities in drug-resistant Mycobacterium tuberculosis

1. Early discovery and development

Tuesday, 22 September

Ozioma Onokala

Isoniazid-loaded nanoparticles: a promising approach to prevention of anti-microbial resistance during tuberculosis preventive treatment

2. Preclinical development

Tuesday, 22 September

Eric van Der Helm

Safety, recovery, and pharmacodynamics of CRISPR–Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study

3. Clinical development

Tuesday, 22 September

Guy Hermans

Systematic engineering of lysins yields serum resistant and in vivo active compounds towards drug-resistant Acinetobacter baumannii

4. New antibacterial or antifungal classes

Tuesday, 22 September

Jörg Haupenthal

Development of inhibitors of Pseudomonas aeruginosa LasB for the treatment of acute lung and eye infections.

5. Non-traditional approaches

Tuesday, 22 September

Zahara Nahumuza

Closing the last-mile gap in antimicrobial stewardship: behaviourally optimised rapid diagnostics in Nakivaleand Kyangwali refugee settlements, Uganda

6. Stewardship, antimicrobial supply and access

Wednesday, 23 September

Stephanie Delzell

An instrument-free rapid AST: improvements in performance and turnaround time

7. AMR diagnostics

Wednesday, 23 September

Seun Olufemi

Designing a multi-epitope vaccine against Streptococcus agalactiae to address antimicrobial resistance and neonatal infections globally

8. Preventatives / vaccines

Wednesday, 23 September

Tomislav Mestrovic

Current challenges to meet UNGA’s commitment in worldwide reduction of deaths associated with antimicrobial resistance: insights from analysing age-specific trends in global AMR mortality

9. AMR epidemiology

Wednesday, 23 September

Subscribe for updates

Would you like to receive news about GAMRIC to stay up to date? Then subscribe to our newsletter.

Please note that you will receive an email from ESCMID asking you to confirm your newsletter registration. Your registration will only be active after your confirmation.